Discontinuation of Tobacco Dependence in Smoking Patients With Squamous Cell Carcinoma of the Head-neck District: Multicenter Prospective Observational Study
NCT06995417 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-05-29
Summary
The primary objective of our study is to evaluate the effectiveness of a standardized clinical practice counseling strategy for promoting post-diagnosis smoking cessation among patients with SCCHN. Efficacy will be measured as the percentage of patients who succeed in sustained smoking cessation ("sustained quitters," see below) at 6+1 months after enrollment, i.e., after the initiation of anti-smoking counseling.
Conditions
- Cancer of Head and Neck
Interventions
- OTHER
-
Smoking counseling
The investigator, upon enrollment, will initiate a standardized strategy from clinical practice: the investigator will conduct brief counseling ("minimal advice") using the administration of of a questionnaire that will include, in addition to questions about current and past, the administration of the Fagerstrom test to measure physical dependence on nicotine and questions to investigate intention to quit smoking (Mondor test)
Sponsors & Collaborators
-
Azienda Ospedaliero-Universitaria Careggi
lead OTHER
Principal Investigators
-
LORENZO LL LIVI, MEDICAL DOCTOR · Aou Careggi
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2025-12-31
- Completion
- 2030-05-31
Countries
- Italy
Study Locations
More Related Trials
-
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)
NCT00357149 ·Status: COMPLETED ·Phase: PHASE2
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
NCT03519048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients
NCT02025062 ·Status: COMPLETED ·Phase: NA
-
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT05992610 ·Status: RECRUITING ·Phase: NA
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT05544136 ·Status: RECRUITING ·Phase: PHASE2
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420 ·Status: RECRUITING ·Phase: NA
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
NCT05494190 ·Status: RECRUITING ·Phase: NA
-
Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention
NCT02869399 ·Status: COMPLETED ·Phase: NA
-
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02778191 ·Status: COMPLETED
-
A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC
NCT03276819 ·Status: TERMINATED ·Phase: NA
-
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00020189 ·Status: COMPLETED ·Phase: PHASE2
-
Re-irradiation of Recurrent Head and Neck Cancer
NCT01973179 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01086826 ·Status: COMPLETED ·Phase: PHASE3
-
Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin
NCT00999700 ·Status: UNKNOWN ·Phase: PHASE3
-
Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells
NCT01484769 ·Status: WITHDRAWN
-
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2
-
Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034 ·Status: UNKNOWN ·Phase: NA
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT03129061 ·Status: COMPLETED ·Phase: PHASE1